The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cardiotoxicity
Related studies linked through entity extraction aliases.
Prediction of Delayed Toxic Cardiomyopathy in Children
- Status
- TERMINATED
- Phase
- NA
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
- Status
- RECRUITING
- Phase
- NA
Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors
- Status
- TERMINATED
- Phase
- NA
Cardiotoxicity Monitoring With Single-lead Electrocardiogram
- Status
- COMPLETED
- Phase
- NA
Global Cardio Oncology Registry
- Status
- RECRUITING
- Phase
- N/A
Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.
- Status
- COMPLETED
- Phase
- NA
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
- Status
- RECRUITING
- Phase
- PHASE4
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity
- Status
- UNKNOWN
- Phase
- N/A
Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity
- Status
- UNKNOWN
- Phase
- N/A
CAR T Cell Therapy Related Cardiovascular Outcomes
- Status
- COMPLETED
- Phase
- N/A
Atherosclerosis in Chemotherapy-related Cardiotoxicity
- Status
- COMPLETED
- Phase
- N/A